Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9
Nature Genetics2005Vol. 37(2), pp. 161–165
Citations Over TimeTop 1% of 2005 papers
Jonathan C. Cohen, Alexander Pertsemlidis, Ingrid K. Kotowski, Randall B. Graham, Christine Kim Garcia, Helen H. Hobbs
Related Papers
- → Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Can Mediate Degradation of the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1)(2013)231 cited
- → On the function and homeostasis of PCSK9: Reciprocal interaction with LDLR and additional lipid effects(2014)80 cited
- → PCSK9 Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis(2020)51 cited
- → LDLR, PCSK9, and LDLRAP1 mutations in the same patient in a familial hypercholesterolemia (FH) family(2017)
- → Development and functional analysis of novel PCSK9/LDLR interaction inhibitors for hypercholesterolemia treatment(2021)